Harnessing oncolytic virus-mediated antitumor immunity in an infected cell vaccine.
Lemay CG, Rintoul JL, Kus A, Paterson JM, Garcia V, Falls TJ, Ferreira L, Bridle BW, Conrad DP, Tang VA, Diallo JS, Arulanandam R, Le Boeuf F, Garson K, Vanderhyden BC, Stojdl DF, Lichty BD, Atkins HL, Parato KA, Bell JC, Auer RC.
Lemay CG, et al. Among authors: le boeuf f.
Mol Ther. 2012 Sep;20(9):1791-9. doi: 10.1038/mt.2012.128. Epub 2012 Jul 3.
Mol Ther. 2012.
PMID: 22760544
Free PMC article.